The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom.

OBJECTIVE To determine whether the incidence of herpes zoster is elevated in patients with rheumatoid arthritis (RA) and whether herpes zoster is associated with use of disease-modifying antirheumatic drugs (DMARDs) in patients with RA. METHODS Two retrospective cohort studies were conducted using data from a US integrated managed care database (PharMetrics claims database) from 1998-2002 and the UK General Practice Research Database (GPRD) between 1990-2001. Rates of herpes zoster among patients with RA and randomly sampled non-RA patients were compared. A nested case-control analysis was performed within each RA cohort to examine the effect of current treatment on herpes zoster risk. RESULTS A total of 122,272 patients with RA from the PharMetrics database and 38,621 from the GPRD were included. The adjusted hazard ratios of herpes zoster for patients with RA compared with non-RA patients were 1.91 (95% confidence interval [95% CI] 1.80-2.03) in the PharMetrics database and 1.65 (95% CI 1.57-1.75) in the GPRD. In the PharMetrics database, current use of biologic DMARDs alone was associated with herpes zoster (odds ratio [OR] 1.54, 95% CI 1.04-2.29), as was current use of traditional DMARDs alone (OR 1.37, 95% CI 1.18-1.59). In the GPRD, current use of traditional DMARDs was associated with herpes zoster (OR 1.27, 95% CI 1.10-1.48). In both data sources, use of oral corticosteroids was associated with herpes zoster regardless of concomitant therapies. CONCLUSION Data from 2 large databases suggested that patients with RA are at increased risk of herpes zoster. Among patients with RA, DMARDs and/or use of oral corticosteroids appeared to be associated with herpes zoster.

[1]  J. Alcocer-Varela,et al.  Development, recurrence, and severity of infections in Mexican patients with rheumatoid arthritis. A nested case-control study. , 1998, The Journal of rheumatology.

[2]  R. Reichman,et al.  Herpes Zoster-Varicella Infections in Immunosuppressed Patients , 1978 .

[3]  F. Wolfe,et al.  Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders. , 2006, Rheumatology.

[4]  D. Ching.  Severe, disseminated, life threatening herpes zoster infection in a patient with rheumatoid arthritis treated with methotrexate. , 1995, Annals of the rheumatic diseases.

[5]  A. Silman,et al.  Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. , 2006, Arthritis and rheumatism.

[6]  W. O'Fallon,et al.  T cell homeostasis in patients with rheumatoid arthritis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  D. Thompson,et al.  Herpes zoster encephalomyelitis associated with low dose methotrexate for rheumatoid arthritis. , 1997, The Journal of rheumatology.

[8]  D. Cowan,et al.  Herpes zoster during gold therapy. , 1981, Annals of internal medicine.

[9]  H. Jick,et al.  Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel , 2006, Journal of Family Planning and Reproductive Health Care.

[10]  H Jick,et al.  Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. , 1991, BMJ.

[11]  Corri Black,et al.  Validity of the General Practice Research Database , 2003, Pharmacotherapy.

[12]  D. Symmons,et al.  Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. , 1998, The Journal of rheumatology.

[13]  A. Stuck,et al.  Risk of infectious complications in patients taking glucocorticosteroids. , 1989, Reviews of infectious diseases.

[14]  O. Førre,et al.  Natural killer (NK) cell activity of peripheral blood, synovial fluid, and synovial tissue lymphocytes from patients with rheumatoid arthritis and juvenile rheumatoid arthritis. , 1982, Annals of the rheumatic diseases.

[15]  A. van der Heide,et al.  Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate. , 1994, Annals of the rheumatic diseases.

[16]  S. Gabriel,et al.  Predictors of infection in rheumatoid arthritis. , 2002, Arthritis and rheumatism.

[17]  I. Buchan,et al.  Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. , 2006, JAMA.

[18]  D. Anderson,et al.  Herpes zoster infection in a patient on methotrexate given prednisone to prevent post-herpetic neuralgia. , 1987, Annals of Internal Medicine.

[19]  R. Fox,et al.  Characterization of recirculating lymphocytes in rheumatoid arthritis patients: selective deficiency of natural killer cells in thoracic duct lymph. , 1984, Journal of immunology.

[20]  Matthias Schneider,et al.  Infections in patients with rheumatoid arthritis treated with biologic agents. , 2005, Arthritis and rheumatism.

[21]  Frederick Wolfe,et al.  Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy. , 2006, Arthritis and rheumatism.

[22]  M. Finch,et al.  Case Number 22: An interesting case of herpes zoster in rheumatoid arthritis , 2002, Annals of the rheumatic diseases.

[23]  S. Gutthann,et al.  Use of the UK General Practice Research Database for pharmacoepidemiology. , 1998, British journal of clinical pharmacology.

[24]  G. Oster,et al.  Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study. , 2003, Diabetes care.

[25]  Hope-Simpson Re.  THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS. , 1965 .

[26]  M. Sawyer,et al.  Varicella-Zoster Virus Infections: Biology, Natural History, Treatment, and Prevention , 1988 .

[27]  F. Wolfe,et al.  The mortality of rheumatoid arthritis. , 1994, Arthritis and rheumatism.

[28]  W. Eckhardt,et al.  Severe herpes zoster during corticosteroid therapy. Report of a severe attack in a patient with rheumatoid arthritis. , 1961, Archives of internal medicine.

[29]  A. Kinder,et al.  Severe herpes zoster after infliximab infusion , 2004, Postgraduate Medical Journal.

[30]  A. Bitton,et al.  Newer disease-modifying antirheumatic drugs and the risk of serious hepatic adverse events in patients with rheumatoid arthritis. , 2004, The American journal of medicine.

[31]  R. Cohrs,et al.  Neurologic complications of the reactivation of varicella-zoster virus. , 2000, The New England journal of medicine.

[32]  R Platt,et al.  The epidemiology of varicella and its complications. , 1995, The Journal of infectious diseases.

[33]  S. Suissa.  Novel Approaches to Pharmacoepidemiology Study Design and Statistical Analysis , 2002 .

[34]  David W Wareham,et al.  Herpes zoster , 2007, BMJ : British Medical Journal.

[35]  R. Whitley,et al.  Clinical practice. Herpes zoster. , 2002, The New England journal of medicine.

[36]  A. Hall,et al.  For Personal Use. Only Reproduce with Permission from the Lancet. Review Risk Factors for Herpes Zoster What Does Epidemiology Tell Us about Risk Factors for Herpes Zoster? , 2022 .

[37]  L. Moreland,et al.  Herpes zoster in patients with rheumatoid arthritis treated with weekly, low-dose methotrexate. , 1991, The American journal of medicine.

[38]  S. Gabriel,et al.  Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. , 2002, Arthritis and rheumatism.

[39]  Susan S. Jick,et al.  Further validation of information recorded on a general practitioner based computerized data resource in the united kingdom , 1992 .

[40]  C. Paul,et al.  Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. , 2007, The Journal of investigative dermatology.

[41]  J. Fries,et al.  Survival, prognosis, and causes of death in rheumatoid arthritis. , 1986, Arthritis and rheumatism.

[42]  K. Schmader,et al.  Herpes zoster in older adults. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.